Sign in
Taking people in United StatesNo phase

Short group therapy for insomnia, nightmares and PTSD together

Tests sleep-focused talk therapy alongside PTSD therapy in adults with insomnia, nightmares and PTSD.

Key facts

Who runs it
Palo Alto Veterans Institute for Research
Where
Kileen, United StatesSee the site
Trial code
Registry title
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
Status
Recruiting
People taking part
160 people, planned
Started
2 Dec 2025
Expected to end
1 Dec 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cognitive-Behavioral Therapy for Insomnia (CBTi)
  • Cognitive Behavioral Therapy for Nightmares (CBTn)
  • Written Exposure Therapy (WET)
  • Sleep Hygiene
Record updated
3 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for active-duty military personnel or veterans with PTSD, insomnia and nightmares. They must be listed in the military benefits system DEERS.

Age
18 to 65 years
Sex
All sexes
Disease stage
Clear PTSD symptoms (CAPS-5 score above 25, with at least one intrusion symptom and one avoidance symptom). Insomnia disorder (SCISD criteria met and Insomnia Severity Index above 11). Nightmares more than 1 time a month.
Earlier treatment
People cannot join if they are now in a proven talk therapy for PTSD, insomnia or nightmares. Examples are Prolonged Exposure Therapy, Cognitive Processing Therapy, Written Exposure Therapy, or CBT for insomnia or nightmares. People must agree not to start new therapy or medicine for PTSD, sleep or nightmares during the study.

Main reasons for not taking part

  • Current risk of suicide or of harming others that needs crisis care
  • Serious mental health problems needing urgent care, such as mania, psychosis, or alcohol or drug use disorders
  • Pregnancy, by the person's own report
  • Duty shifts ending after 21:00 or starting before 05:30 more than 2 times a month
  • Not able to speak and read English, or not willing to avoid alcohol during therapy sessions

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Defense Enrollment Eligibility Reporting System (DEERS) eligible active-duty military personnel or veteran, 18-65 years old
  • Ability to speak and read English
  • Clinically significant PTSD symptoms (CAPS-5 > 25 with at least one Intrusion symptom and at least one Avoidance symptom)
  • Clinically significant symptoms of insomnia disorder (Structured Clinical Interview for Sleep Disturbance DSM-5 (SCISD) Insomnia Criteria are met and Insomnia Severity Index (ISI) > 11)
  • Nightmares > 1 monthly (as reported on the SCISD)
  • Willing to refrain from new behavioral health or medication treatment for issues pertaining to PTSD, sleep, and nightmares during study participation

Who cannot take part

  • Unwilling to remain abstinent from alcohol during therapy sessions
  • Currently engaged in evidence-based psychotherapy for PTSD (e.g., Prolonged Exposure Therapy, Cognitive Processing Therapy, Written Exposure Therapy) or insomnia or nightmares (e.g., Cognitive Behavioral Therapy for Insomnia or Nightmares)
  • Serious mental health symptoms, such as mania, psychosis, alcohol or substance use disorders warranting immediate clinical attention based on interviewer assessment and clinical judgement
  • Current suicide or homicide risk meriting crisis intervention
  • Inability to comprehend the baseline screening questionnaires
  • Pregnancy, as determined by self-report, because pregnancy can adversely affect sleep outside of PTSD, insomnia, and nightmares
  • Working duty shifts ending later than 21:00 or starting before 05:30 more than 2 times per month

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • Fort HoodKileen, United StatesContact: Bryce WilliamsTaking people

About the trial

What the trial wants to find out

This study is a two-arm individually randomized group treatment clinical trial evaluating behavioral therapies for insomnia, nightmares, and PTSD. The study will compare cognitive-behavioral therapy for insomnia and nightmares to sleep hygiene (Control), both integrated with Written Exposure Therapy for PTSD and delivered in an accelerated (i.e., 5-day) group treatment format, preceded and followed by individual treatment sessions. 160 participants will be randomized into one of two study conditions.

The 2 groups in the trial

  • Written exposure therapy and sleep hygiene for insomnia and nightmaresExisting treatment, for comparison

    Treatment: Written Exposure Therapy (WET) and Sleep Hygiene

  • Written exposure therapy and CBT for insomnia and nightmaresTreatment being tested

    Treatment: Cognitive-Behavioral Therapy for Insomnia (CBTi), Cognitive Behavioral Therapy for Nightmares (CBTn), and Written Exposure Therapy (WET)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD: A Randomized Controlled Trial
Plain-language title
Short group therapy for insomnia, nightmares and PTSD togetherGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07069517, who can take part
Record updated
3 December 2025